SMILE CARE

Basma Adeem Medical Co.

9626StocksTadawulHealthcare

Financials

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	101.94M	103.04M	—	—	—
Enterprise Value	76.86M	80.03M	—	—	—
Last Close Price	5.54	5.60	—	—	—
Valuation Multiples
PE Ratio	13.85	14.11	—	—	—
PS Ratio	2.24	2.27	—	—	—
PB Ratio	2.21	2.24	—	—	—
P/TBV Ratio	2.21	2.24	—	—	—
P/FCF Ratio	21.41	21.64	—	—	—
P/OCF Ratio	8.97	9.07	—	—	—
EV/Sales Ratio	1.69	1.76	—	—	—
EV/EBITDA Ratio	7.12	8.78	—	—	—
EV/EBIT Ratio	9.51	9.90	—	—	—
EV/FCF Ratio	16.14	16.81	—	—	—
Leverage & Capital
Debt / Equity Ratio	0.31	0.31	0.53	0.45	1.04
Debt / EBITDA Ratio	1.32	1.32	1.34	0.65	1.03
Debt / FCF Ratio	3.00	3.00	1.77	1.07	0.98
Net Debt / Equity Ratio	-0.54	-0.54	-0.37	-0.38	-0.01
Net Debt / EBITDA Ratio	-2.75	-2.75	-1.01	-0.61	-0.01
Net Debt / FCF Ratio	-5.27	-5.27	-1.24	-0.92	-0.01
Efficiency & Liquidity
Asset Turnover	0.87	0.87	1.24	1.77	—
Inventory Turnover	27.86	27.86	26.34	50.42	—
Quick Ratio	6.01	6.01	4.85	2.44	1.81
Current Ratio	6.55	6.55	5.21	2.73	1.90
Returns & Yields
Return on Equity (ROE)	+21.4%	+21.4%	+39.2%	+66.1%	—
Return on Assets (ROA)	+9.7%	+9.7%	+17.1%	+23.2%	—
Return on Invested Capital (ROIC)	+34.1%	+40.8%	+69.5%	+98.2%	+82.8%
Return on Capital Employed (ROCE)	+13.5%	+13.5%	+22.4%	+41.6%	+42.1%
Earnings Yield	+7.2%	+7.1%	—	—	—
FCF Yield	+4.7%	+4.6%	—	—	—
Payout Ratio	—	—	—	—	+95.2%
Buyback Yield / Dilution	-59.4%	-58.1%	-21.6%	—	—

SAR 5.46

Official close

-1.4%

Price as of March 29, 2026 · Market close

Prices may be delayed by up to 30 minutes.

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	101.94M	103.04M	—	—	—
Enterprise Value	76.86M	80.03M	—	—	—
Last Close Price	5.54	5.60	—	—	—
Valuation Multiples
PE Ratio	13.85	14.11	—	—	—
PS Ratio	2.24	2.27	—	—	—
PB Ratio	2.21	2.24	—	—	—
P/TBV Ratio	2.21	2.24	—	—	—
P/FCF Ratio	21.41	21.64	—	—	—
P/OCF Ratio	8.97	9.07	—	—	—
EV/Sales Ratio	1.69	1.76	—	—	—
EV/EBITDA Ratio	7.12	8.78	—	—	—
EV/EBIT Ratio	9.51	9.90	—	—	—
EV/FCF Ratio	16.14	16.81	—	—	—
Leverage & Capital
Debt / Equity Ratio	0.31	0.31	0.53	0.45	1.04
Debt / EBITDA Ratio	1.32	1.32	1.34	0.65	1.03
Debt / FCF Ratio	3.00	3.00	1.77	1.07	0.98
Net Debt / Equity Ratio	-0.54	-0.54	-0.37	-0.38	-0.01
Net Debt / EBITDA Ratio	-2.75	-2.75	-1.01	-0.61	-0.01
Net Debt / FCF Ratio	-5.27	-5.27	-1.24	-0.92	-0.01
Efficiency & Liquidity
Asset Turnover	0.87	0.87	1.24	1.77	—
Inventory Turnover	27.86	27.86	26.34	50.42	—
Quick Ratio	6.01	6.01	4.85	2.44	1.81
Current Ratio	6.55	6.55	5.21	2.73	1.90
Returns & Yields
Return on Equity (ROE)	+21.4%	+21.4%	+39.2%	+66.1%	—
Return on Assets (ROA)	+9.7%	+9.7%	+17.1%	+23.2%	—
Return on Invested Capital (ROIC)	+34.1%	+40.8%	+69.5%	+98.2%	+82.8%
Return on Capital Employed (ROCE)	+13.5%	+13.5%	+22.4%	+41.6%	+42.1%
Earnings Yield	+7.2%	+7.1%	—	—	—
FCF Yield	+4.7%	+4.6%	—	—	—
Payout Ratio	—	—	—	—	+95.2%
Buyback Yield / Dilution	-59.4%	-58.1%	-21.6%	—	—